JPRN-UMIN000002538
Recruiting
未知
Evaluation and treatment of patients with unilateral vocal fold paralysis - Evaluation and treatment of patients with unilateral vocal fold paralysis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Patients with unilateral vocal fold paralysis
- Sponsor
- Kumamoto University
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients without unilateral vocal fold paralysis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Maha analuruva chooranam (internal) and Chennagarapattai ennai (external)for the management of Baalavatham(Paresis) in childreHealth Condition 1: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhereCTRI/2021/08/035549ational Institute of Siddha30
Completed
Not Applicable
Early treatment of patients with undifferentiated arthritis (UA) with Methotrexate (MTX)ndifferentiated arthritis, probable rheumatoid arthritis according to ACR-1958 criteriaMusculoskeletal DiseasesOther arthrosisISRCTN21334657eiden University Medical Center (LUMC) (Netherlands)110
Recruiting
Not Applicable
Investigation of clinical course and treatment of acute exacerbation of interstitial lung disease - A Prospective Observational StudyJPRN-UMIN000043154Hamamatsu University School of Medicine400
Recruiting
Not Applicable
Evaluation of treatment regimes in patients with cystic fibrosis and pulmonary excerbations (PEx)E84.0Cystic fibrosis with pulmonary manifestationsDRKS00012924Klinik für Pädiatrie m. S. Pneumologie und ImmunologieCampus Rudolf Virchow Klinikum100
Not yet recruiting
Phase 2
Clinical management of maantha sanni(Autism spectrum disorder)with maantha sanni thylam(Internal&External)Health Condition 1: null- 1 Poor eye contact 2 Mild aggresive behavior 3 Repetative behavior 4 Lack of communication skillsCTRI/2018/08/015287ATIONAL INSTITUTE OF SIDDHA